September 9, 2020
Tag: CAR-T
August 13, 2020
CURE: Novel CAR T-Cell Therapy Shows Promise in Advanced Hodgkin Lymphoma
August 12, 2020
BioWorld: Tessa enjoys positive results from two phase I/II trials of CD30 CAR T-cell therapy
August 6, 2020
Targeted Oncology: Autologous CAR T-Cell Therapy Induces Durable Responses in Relapsed/Refractory Hodgkin Lymphoma
August 6, 2020
OncLive: CD30-Targeted CAR T-Cell Therapy Elicits Durable Responses in Relapsed/Refractory Hodgkin Lymphoma
August 5, 2020
HemOnc Today: Anti-CD30 CAR T-cell therapy appears safe, effective in advanced Hodgkin lymphoma
July 30, 2020
MedPage Today: CAR-T Safe, Active in Hodgkin Lymphoma
July 24, 2020
OncoZine: Anti-CD30 CAR-T Cell Therapy Shows Promising Results in Relapsed and Refractory Hodgkin Lymphoma
![Barbara Savoldo and Natalie Grover](https://unclineberger.org/wp-content/uploads/sites/867/2020/07/Savoldo-Grover-feature-600x400.jpg)
July 23, 2020
Excellent research results for CAR-T therapy against Hodgkin lymphoma
CAR-T immunotherapy has been used to treat Hodgkin lymphoma with remarkable success for the first time, according to the results of an early phase clinical trial.
![](https://unclineberger.org/wp-content/uploads/sites/867/2020/05/844A9423-600x400.jpg)
May 21, 2020
A cancer journey provides a new career path
After two cancer diagnoses and multiple rounds of treatment, Lauren Gift’s cancer journey inspired her to help others navigate cancer treatment.